Catherine Cassiman

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The diagnosis of a paraneoplastic syndrome (PNS) is challenging as it comprises a group of clinically heterogeneous entities, all related to a coexistent, but sometimes occult, malignancy. 1 The detection of paraneoplastic antibodies aids the clinician to establish the diagnosis of a PNS. 2 Paraneoplastic antibodies are screened for by means of(More)
PURPOSE Efforts are made to unify the protocol concerning the ophthalmological screening, monitoring and treatment of Optic Pathway Gliomas (OPGs) in children with neurofibromatosis type 1 (NF1). The aim of this study is to compare the most recent recommendations published in 2007 with the screening strategies in NF1 centres. The integration of these data(More)
BACKGROUND Paraneoplastic melanocytic proliferation (bilateral diffuse uveal melanocytic proliferation, BDUMP) is a rare but devastating disease that causes progressive visual loss in patients who usually have an occult malignancy. Visual loss occurs as a result of paraneoplastic changes in the uveal tissue. METHODS In a masked fashion, the serum of two(More)
  • 1